Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds
US7026322B2 · kind B2 · utility
62Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 1, 2003 |
| Grant date | Apr 11, 2006 |
| Priority date | — |
| Expiry date | Aug 1, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods of using a compound, its pharmaceutically acceptable salts, and/or its pro-drug esters, in isolated form, to treat cancer, and methods for isolating, for formulating, and for administering the compound, salt, and/or pro-drug ester as an antitumor agent, wherein the compound, salt, or pro-drug ester has the following structure:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.